 Trevena continues to struggle to get OLINVYK off the launch pad. COVID-19 headwinds are persisting, and it is having an impact on the companys ability to get through PT committees. Trevena is building a body of evidence in OLINVYKs post-approval program. The company expects these additional studies should improve product adoption and potentially expand OLINVYKs label. 